Samuel H. Sigal

8.1k total citations · 2 hit papers
80 papers, 4.2k citations indexed

About

Samuel H. Sigal is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Samuel H. Sigal has authored 80 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hepatology, 44 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Samuel H. Sigal's work include Liver Disease Diagnosis and Treatment (37 papers), Liver Disease and Transplantation (30 papers) and Hepatitis C virus research (23 papers). Samuel H. Sigal is often cited by papers focused on Liver Disease Diagnosis and Treatment (37 papers), Liver Disease and Transplantation (30 papers) and Hepatitis C virus research (23 papers). Samuel H. Sigal collaborates with scholars based in United States, Italy and United Kingdom. Samuel H. Sigal's co-authors include Arun J. Sanyal, Lola M. Reid, Shlomo Brill, Guadalupe García–Tsao, Lewis Teperman, Kimberly L. Beavers, Kunal Merchant, Fred Poordad, William P. Forbes and Enoch Bortey and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Samuel H. Sigal

75 papers receiving 4.1k citations

Hit Papers

Rifaximin Treatment in Hepatic Encephalopathy 2010 2026 2015 2020 2010 2014 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rifaximin Treatment in Hepatic Encephalopathy
    2010 848 citations Nathan M. Bass, Kevin D. Mullen et al. New England Journal of Medicine profile →
  2. Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
    2014 686 citations Jordan J. Feld, Kris V. Kowdley et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel H. Sigal United States 25 2.8k 2.4k 1.4k 477 406 80 4.2k
Jane Collier United Kingdom 32 2.2k 0.8× 2.4k 1.0× 930 0.7× 632 1.3× 359 0.9× 91 4.3k
John C. Hoefs United States 30 3.8k 1.3× 3.5k 1.4× 848 0.6× 381 0.8× 255 0.6× 73 5.2k
P. Michielsen Belgium 34 1.5k 0.5× 2.1k 0.9× 662 0.5× 472 1.0× 286 0.7× 219 4.0k
Pierluigi Toniutto Italy 35 2.7k 0.9× 2.6k 1.1× 938 0.7× 301 0.6× 226 0.6× 179 4.2k
Arie Regev United States 34 2.6k 0.9× 2.8k 1.2× 936 0.7× 335 0.7× 213 0.5× 95 4.7k
José Luís Calleja Spain 40 4.4k 1.5× 4.2k 1.7× 1.4k 1.0× 255 0.5× 419 1.0× 267 6.1k
Allan Rasmussen Denmark 33 1.6k 0.5× 1.2k 0.5× 1.6k 1.2× 350 0.7× 442 1.1× 183 3.9k
Lewis Teperman United States 34 4.7k 1.6× 3.6k 1.5× 3.1k 2.2× 562 1.2× 407 1.0× 98 7.0k
Maurizio Pompili Italy 39 3.2k 1.1× 2.9k 1.2× 1.3k 0.9× 945 2.0× 650 1.6× 231 6.0k
P McMaster United Kingdom 38 2.4k 0.8× 1.3k 0.6× 3.0k 2.1× 520 1.1× 646 1.6× 178 5.7k

Countries citing papers authored by Samuel H. Sigal

Since Specialization
Citations

This map shows the geographic impact of Samuel H. Sigal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel H. Sigal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel H. Sigal more than expected).

Fields of papers citing papers by Samuel H. Sigal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel H. Sigal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel H. Sigal. The network helps show where Samuel H. Sigal may publish in the future.

Co-authorship network of co-authors of Samuel H. Sigal

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel H. Sigal. A scholar is included among the top collaborators of Samuel H. Sigal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel H. Sigal. Samuel H. Sigal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Julie, et al.. (2024). Screening for hepatitis B in the Bronx West African community with a blood pressure cuff: a cohort study. The Lancet Regional Health - Americas. 35. 100780–100780. 1 indexed citations
2.
3.
Merola, Jonathan, Brett E. Fortune, Yanhong Deng, et al.. (2018). Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis. European Journal of Gastroenterology & Hepatology. 30(6). 668–675. 5 indexed citations
4.
Sigal, Samuel H., et al.. (2017). Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center. Human Pathology. 68. 92–98. 16 indexed citations
5.
Giannini, Edoardo G., Nezam H. Afdhal, Samuel H. Sigal, et al.. (2015). Non‐cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy. Journal of Gastroenterology and Hepatology. 30(8). 1301–1308. 4 indexed citations
6.
Greenberg, Arthur, Joseph G. Verbalis, Alpesh Amin, et al.. (2015). Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney International. 88(1). 167–177. 131 indexed citations
7.
8.
Feld, Jordan J., Kris V. Kowdley, Eoin Coakley, et al.. (2014). Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin. New England Journal of Medicine. 370(17). 1594–1603. 686 indexed citations breakdown →
9.
Sigal, Samuel H., et al.. (2012). Sirolimus-associated hepatotoxicity: case report and review of the literature. SHILAP Revista de lepidopterología. 1–1.
10.
Bass, Nathan M., Kevin D. Mullen, Arun J. Sanyal, et al.. (2010). Rifaximin Treatment in Hepatic Encephalopathy. New England Journal of Medicine. 362(12). 1071–1081. 848 indexed citations breakdown →
11.
12.
Ross, Elizabeth & Samuel H. Sigal. (2010). Managing hyponatremia in cirrhosis. Journal of Hospital Medicine. 5(S3). S8–17. 3 indexed citations
13.
Weisberg, Ilan, et al.. (2009). 234 THE ROLE OF SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) IN HEPATIC ENCEPHALOPATHY. Journal of Hepatology. 50. S94–S95. 2 indexed citations
14.
Mullen, Kathleen, Samuel H. Sigal, Mahdi Sheikh, et al.. (2009). 207 SAFETY OF RIFAXIMIN IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: RESULTS OF A RANDOMIZED, PHASE 3, PLACEBO-CONTROLLED CLINICAL TRIAL. Journal of Hepatology. 50. S84–S85. 4 indexed citations
15.
Sigal, Samuel H. & Ira M. Jacobson. (2007). Future therapies for hepatitis C: where do we go from here?. Nature Clinical Practice Gastroenterology & Hepatology. 4(2). 60–61. 4 indexed citations
16.
Russo, Mark W., et al.. (2005). Randomized trial of pegylated interferon α-2b monotherapy in haemodialysis patients with chronic hepatitis C. Nephrology Dialysis Transplantation. 21(2). 437–443. 71 indexed citations
17.
Wasserman, Jared M., Swan N. Thung, Richard Berman, Henry C. Bodenheimer, & Samuel H. Sigal. (2001). Hepatic Weber-Christian Disease. Seminars in Liver Disease. 21(1). 115–118. 19 indexed citations
18.
Brill, Shlomo, Peter Johannes Holst, Samuel H. Sigal, et al.. (1993). Hepatic Progenitor Populations in Embryonic, Neonatal, and Adult Liver. Experimental Biology and Medicine. 204(3). 261–269. 63 indexed citations
19.
Sigal, Samuel H., John R. Yandrasitz, & Gerard T. Berry. (1993). Kinetic evidence for compartmentalization of myo-inositol in hepatocytes. Metabolism. 42(3). 395–401. 17 indexed citations
20.
Sigal, Samuel H., Charles A. Hall, & Jack P. Antel. (1987). Plasma R Binder Deficiency and Neurologic Disease. New England Journal of Medicine. 317(21). 1330–1332. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane Collier Breakdown of academic impact, for papers by John C. Hoefs Breakdown of academic impact, for papers by P. Michielsen Breakdown of academic impact, for papers by Pierluigi Toniutto Breakdown of academic impact, for papers by Arie Regev Breakdown of academic impact, for papers by José Luís Calleja Breakdown of academic impact, for papers by Allan Rasmussen Breakdown of academic impact, for papers by Lewis Teperman Breakdown of academic impact, for papers by Maurizio Pompili Breakdown of academic impact, for papers by P McMaster
Rankless by CCL
2026